Impairment Risk for Property, Plant and Equipment, Goodwill and Investment Securities
First written in FY2019. 10 of 11 entries say "Materialised", first in FY2020-Q2. Latest entry: FY2025.
The whole theme swung hardest in 2020: 51 of 96 companies on the "Worse" side.
- FY2025MaterialisedAnnual report
「During the current consolidated fiscal year, as the profitability of ㈱シードアイサービス and SEED Contact Lens ASIA Pte.Ltd. was expected to decline due to deterioration in the business environment and other factors, the company reduced their carrying amounts to their recoverable amounts and recognized impairment losses and extraordinary losses of ¥3.809 million on buildings and structures, ¥449 thousand on other tangible fixed assets, and ¥4.529 million on other intangible fixed assets.」
シードアイサービス and the Singapore subsidiary recognized ¥8.788 million in impairment losses associated with declining profitability, realizing the risk of declining profitability in fixed assets and the subsidiary's business. - FY2024-Q2MaterialisedAnnual report
「Extraordinary losses Loss on disposal of fixed assets 2 Valuation loss on investment securities 1,647 Building demolition costs － Valuation loss on shares of affiliates 21,399」
During the current second quarter cumulative period, the company recognized a ¥1.647 million valuation loss on investment securities and a ¥21.399 million valuation loss on shares of affiliates, and valuation losses associated with declining profitability at investees and affiliates continued to occur. - FY2024-Q1MaterialisedAnnual report
「Extraordinary losses Loss on disposal of fixed assets 2 Valuation loss on investment securities 1,647 Valuation loss on shares of affiliates 21,399」
During the first quarter, the company recognized a ¥1.647 million valuation loss on investment securities and a ¥21.399 million valuation loss on shares of affiliates, and valuation losses associated with declining profitability at investees and affiliates continued to occur. - FY2023MaterialisedAnnual report
「As the profitability of the other intangible fixed assets identified at Contact Lens Precision Laboratories Ltd. was expected to decline due to deterioration in the business environment and other factors, the company reduced their carrying amounts to their recoverable amounts and recognized goodwill of ¥271.853 million and other intangible fixed assets of ¥152.903 million as impairment losses and extraordinary losses.」
The company recognized impairment losses of ¥271.853 million on goodwill and ¥152.903 million on intangible fixed assets related to CLPL, realizing the risk of declining asset profitability. - FY2022MaterialisedAnnual report
「Valuation loss on shares of an affiliate 50,633」
The company recognized a ¥50.633 million valuation loss on shares of an affiliate, and the impairment risk associated with declining profitability at investees and affiliates continued to materialize. - FY2022-Q3MaterialisedAnnual report
「Valuation loss on shares of an affiliate 50,633」
During the current third quarter cumulative consolidated period, the company recognized a ¥50.633 million valuation loss on shares of an affiliate as an extraordinary loss, and the impairment risk associated with declining profitability at investees and affiliates continued to materialize. - FY2022-Q2MaterialisedAnnual report
「Valuation loss on shares of an affiliate 28,135」
During the current second quarter cumulative consolidated period, the company recognized a ¥28.135 million valuation loss on shares of an affiliate as an extraordinary loss, and the impairment risk associated with declining profitability at investees and affiliates continued to materialize. - FY2021-Q2MaterialisedAnnual report
「With respect to an unconsolidated subsidiary in Australia, the company recognized a ¥70 million valuation loss on shares of an affiliate as an extraordinary loss because no increase in sales was expected due to the spread of the infectious disease and signs of impairment were identified in the investment in that subsidiary.」
As the spread of the infectious disease made an increase in sales at the unconsolidated Australian subsidiary unlikely, the company recognized a ¥70 million valuation loss on shares of the affiliate investment. - FY2020MaterialisedAnnual report
「As the profitability of the other intangible assets identified at Woehlk Contactlinsen GmbH was expected to decline due to deterioration in the business environment and other factors, the company reduced their carrying amounts to their recoverable amounts and recognized goodwill of ¥35.710 million and other intangible assets of ¥47.326 million as impairment losses and extraordinary losses.」
The company recognized impairment losses of ¥35.710 million on goodwill and ¥47.326 million on intangible assets related to Woehlk, realizing the risk of declining asset profitability. - FY2020-Q2MaterialisedAnnual report
「During the current second quarter cumulative consolidated period, the company converted receivables and other claims against Sensimed AG, an investee, into shares. As the company's financial position had not improved, the company estimated the intrinsic value of the shares and recognized an investment securities valuation loss of ¥25.604 million as an extraordinary loss.」
With respect to investment securities, Sensimed AG's financial position did not improve, and the company recognized a ¥25.604 million valuation loss. - FY2019First statedAnnual report
「However, if the profitability of the above assets declines due to changes in the business environment or other factors and an impairment loss is recognized, this could affect the Group's operating results and financial position.」
The company identified impairment risk from declining profitability of tangible fixed assets at factories and retail stores, goodwill and intangible assets arising from acquisitions, and investment securities as a new risk item.